Modulators of G-Protein Coupled Receptors
US-2024383960-A1 · Nov 21, 2024 · US
US2016176931A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016176931-A1 |
| Application number | US-201514974483-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 18, 2015 |
| Priority date | Dec 23, 2014 |
| Publication date | Jun 23, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Protein indicators useful for calcium imaging, in particular, red genetically-encoded calcium indicators (GECIs) disclosed herein rival best-of-class green GECIs in terms of sensitivity for detecting neural activity, and can be monitored in vivo. The presently-disclosed subject matter further includes a method of monitoring cell activity comprising stimulating a cell comprising a red GECI polypeptide; and detecting fluorescence emitted by the cell.
Opening claim text (preview).
We claim: 1 . A nucleic acid molecule comprising a sequence that encodes a genetically encoded calcium indicator (GECI) polypeptide having at least 95% sequence identity to SEQ ID NO:2 or SEQ ID NO:4. 2 . The nucleic acid molecule of claim 1 , comprising a sequence that encodes a GECI polypeptide having at least 99% sequence identity to SEQ ID NO:2 or SEQ ID NO:4. 3 . The nucleic acid molecule of claim 1 , comprising a sequence that encodes a GECI polypeptide consisting of the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:4. 4 . A vector comprising the nucleic acid molecule of claim 1 . 5 . A cell comprising the vector of claim 4 . 6 . A cell comprising the nucleic acid molecule of claim 1 . 7 . A nucleic acid molecule comprising the sequence of SEQ ID NO:1 or SEQ ID NO:3. 8 . A vector comprising the nucleic acid molecule of claim 7 . 9 . A polypeptide comprising a GECI polypeptide sequence having at least 95% sequence identity to SEQ ID NO:2 or SEQ ID NO:4. 10 . The polypeptide of claim 9 , wherein the polypeptide comprises a GECI polypeptide sequence having at least 99% sequence identity to SEQ ID NO:2 or SEQ ID NO:4. 11 . The polypeptide of claim 9 , wherein the polypeptide comprises the sequence of SEQ ID NO:2 or SEQ ID NO:4. 12 . A cell comprising the polypeptide of claim 9 . 13 . A method of monitoring the activity of a cell, comprising: (i) stimulating a cell comprising a polypeptide of claim 9 ; and (ii) detecting fluorescence emitted by the cell. 14 . The method of claim 13 , wherein the cell is in a biological sample from a subject. 15 . The method of claim 14 , wherein the steps are performed in vivo. 16 . The method of claim 15 , wherein the subject is a mouse, a fish, a worm or a fly. 17 . The method of claim 16 , wherein the subject is a mouse and the cell is in the primary visual cortex. 18 . The method of claim 16 , wherein the cell is a motor neuron with terminals in the neuro-muscular junction (NW), a trigeminal neuron, or an ASH neuron. 19 . The method of claim 13 , wherein the detecting step comprises imaging. 20 . The method of claim 13 , wherein the cell is a neuronal cell, a muscle cell or a cardiomyocyte. 21 . A nucleic acid molecule comprising a sequence that encodes a genetically encoded calcium indicator (GECI) polypeptide having at least 95% sequence identity to SEQ ID NO:6. 22 . The nucleic acid molecule of claim 21 , comprising a sequence that encodes a GECI polypeptide having at least 99% sequence identity to SEQ ID NO:6. 23 . The nucleic acid molecule of claim 1 , comprising a sequence that encodes a GECI polypeptide consisting of the amino acid sequence of SEQ ID NO:6. 24 . A vector comprising the nucleic acid molecule of claim 21 . 25 . A cell comprising the vector of claim 24 . 26 . A cell comprising the nucleic acid molecule of claim 21 . 27 . A nucleic acid molecule comprising the sequence of SEQ ID NO:5. 28 . A vector comprising the nucleic acid molecule of claim 27 . 29 . A polypeptide comprising a GECI polypeptide sequence having at least 95% sequence identity to SEQ ID NO:6. 30 . The polypeptide of claim 29 , wherein the polypeptide comprises a GECI polypeptide sequence having at least 99% sequence identity to SEQ ID NO:6. 31 . The polypeptide of claim 29 , wherein the polypeptide comprises the sequence of SEQ ID NO:6. 32 . A cell comprising the polypeptide of claim 29 . 33 . A method of monitoring the activity of a cell, comprising: (i) stimulating a cell comprising a polypeptide of claim 29 ; and (ii) detecting fluorescence emitted by the cell.
Calcium binding proteins, e.g. calmodulin · CPC title
the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo · CPC title
by chemical synthesis · CPC title
involving analysis of members of signalling pathways · CPC title
viral genome or elements thereof as genetic vector · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.